Webinar recap: Implementing Devyser BRCA to evaluate hereditary cancer risk
Hereditary cancers, particularly breast and ovarian cancers, pose a significant risk for many...
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations
BRCA1 variants may generally be divided into three categories: benign variants, which cause no...